These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 9072007)
61. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules. Trovato M; Villari D; Bartolone L; Spinella S; Simone A; Violi MA; Trimarchi F; Batolo D; Benvenga S Thyroid; 1998 Feb; 8(2):125-31. PubMed ID: 9510120 [TBL] [Abstract][Full Text] [Related]
62. Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissues. Bur M; Shiraki W; Masood S Mod Pathol; 1993 Jul; 6(4):469-72. PubMed ID: 8415594 [TBL] [Abstract][Full Text] [Related]
63. Expression of laminin in thyroid gland and thyroid tumors: an immunohistologic study. Miettinen M; Virtanen I Int J Cancer; 1984 Jul; 34(1):27-30. PubMed ID: 6378803 [TBL] [Abstract][Full Text] [Related]
64. Usefulness of cytokeratin-19, galectin-3, and Hector Battifora mesothelial-1 in the diagnosis of benign and malignant thyroid nodules. Cui W; Sang W; Zheng S; Ma Y; Liu X; Zhang W Clin Lab; 2012; 58(7-8):673-80. PubMed ID: 22997967 [TBL] [Abstract][Full Text] [Related]
65. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases. Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673 [TBL] [Abstract][Full Text] [Related]
66. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study]. Gui K Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739 [TBL] [Abstract][Full Text] [Related]
67. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Beesley MF; McLaren KM Histopathology; 2002 Sep; 41(3):236-43. PubMed ID: 12207785 [TBL] [Abstract][Full Text] [Related]
68. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue. Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952 [TBL] [Abstract][Full Text] [Related]
69. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Gaffney RL; Carney JA; Sebo TJ; Erickson LA; Volante M; Papotti M; Lloyd RV Am J Surg Pathol; 2003 Apr; 27(4):494-8. PubMed ID: 12657934 [TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein. Mizukami Y; Hashimoto T; Nonomura A; Michigishi T; Nakamura S; Noguchi M; Matsukawa S J Clin Endocrinol Metab; 1994 Aug; 79(2):616-9. PubMed ID: 8045985 [TBL] [Abstract][Full Text] [Related]
71. [Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers]. Brasanac D; Jancić-Zgurics M; Janković R; Tatić S Srp Arh Celok Lek; 1993; 121(3-7):70-3. PubMed ID: 7716641 [TBL] [Abstract][Full Text] [Related]
72. Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions. Cvejić D; Savin S; Petrović I; Paunović I; Tatić S; Havelka M Acta Chir Iugosl; 2003; 50(3):67-70. PubMed ID: 15179758 [TBL] [Abstract][Full Text] [Related]
73. Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-kilodalton laminin receptor in follicular carcinoma cells. Montuori N; Müller F; De Riu S; Fenzi G; Sobel ME; Rossi G; Vitale M J Clin Endocrinol Metab; 1999 Jun; 84(6):2086-92. PubMed ID: 10372715 [TBL] [Abstract][Full Text] [Related]
74. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens. Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920 [TBL] [Abstract][Full Text] [Related]
75. The significance of the grooved nucleus in thyroid lesions. Scopa CD; Melachrinou M; Saradopoulou C; Merino MJ Mod Pathol; 1993 Nov; 6(6):691-4. PubMed ID: 8302810 [TBL] [Abstract][Full Text] [Related]
76. Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors. Chiariotti L; Berlingieri MT; Battaglia C; Benvenuto G; Martelli ML; Salvatore P; Chiappetta G; Bruni CB; Fusco A Int J Cancer; 1995 Jun; 64(3):171-5. PubMed ID: 7622305 [TBL] [Abstract][Full Text] [Related]
77. Histochemical localization of Statin--a non-proliferation-specific nuclear protein--in nuclei of normal and abnormal human thyroid tissue. Mitmaker B; Kyzer S; Gordon PH; Wang E Eur J Histochem; 1992; 36(2):123-36. PubMed ID: 1380846 [TBL] [Abstract][Full Text] [Related]
78. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. Nozawa Y; Van Belzen N; Van der Made AC; Dinjens WN; Bosman FT J Pathol; 1996 Jan; 178(1):48-52. PubMed ID: 8778315 [TBL] [Abstract][Full Text] [Related]
79. Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia. Nucera C; Mazzon E; Caillou B; Violi MA; Moleti M; Priolo C; Sturniolo G; Puzzolo D; Cavallari V; Trimarchi F; Vermiglio F J Endocrinol Invest; 2005 Feb; 28(2):106-12. PubMed ID: 15887854 [TBL] [Abstract][Full Text] [Related]
80. Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Cunha LL; Marcello MA; Morari EC; Nonogaki S; Conte FF; Gerhard R; Soares FA; Vassallo J; Ward LS Endocr Relat Cancer; 2013 Feb; 20(1):103-10. PubMed ID: 23193072 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]